S10 Ep23: Midweek Takeaway with James Short, CEO of Celadon Pharmaceuticals (AIM:CEL) #CEL
In this episode of the Midweek Takeaway, we’re joined by James Short, CEO of Celadon Pharmaceuticals, to discuss the company’s recent £1 million funding, its decision to delist from AIM, and what that means for its future. We also explore major operational milestones, including progress on EU exports, a Q3 UK product launch, US market entry, expanded growing capacity, and the completion of multiple harvests.
Disclaimer & Declaration of Interest
This podcast may contain paid promotions, including but not limited to sponsorships, endorsements, or affiliate partnerships. The information…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.